Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,559 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Native Cardio, Inc.Biotechnology
Naples, Florida · SAFE (Simple Agreement for Future Equity) · 1 investors · Joseph Pergolizzi, Young Kim
MB Holdings 2025, Inc.Biotechnology
Pasadena, Texas · Equity · 6 investors · Kevin Combs, David Manka
MAIA Biotechnology, Inc.Biotechnology
Chicago, Illinois · Equity, Options, Convertible · 43 investors · Cristian Luput, Jeffrey Himmelreich
NanoMosaic Inc.Biotechnology
Waltham, Massachusetts · Equity · 9 investors · Qimin Quan, John Boyce
Veronica Holdings, LLCBiotechnology
New York, New York · founded 2024 · Equity, Options · 72 investors · Carlos Vazquez, Konstantin Poukalov
SLAM BioTherapeutics, Inc.Biotechnology
Thousand Oaks, California · founded 2022 · Debt, Options, Convertible · 1 investors · David Vennettilli, Theodore Schwartz
Eikon Therapeutics, Inc.Biotechnology
Hayward, California · Equity, Options, Convertible · 27 investors · Robbie Huffines, Joshua Wolfe
Aligos Therapeutics, Inc.Biotechnology
South San Francisco, California · Equity, Options, Convertible · 12 investors · Bridget Martell, Julian Symons
CoRegen, Inc.Biotechnology
Aspen, Colorado · founded 2022 · Equity · 7 investors · Shawn Tomasello, Steve Gorlin
CoRegen, Inc.Biotechnology
Aspen, Colorado · founded 2022 · Equity · 1 investors · Edward Benz, Jr., Lee Fleisher, M.D.
Maxymune Therapeutics, Inc.Biotechnology
Los Altos, California · founded 2023 · Options · 8 investors · Tatjana Naranda, Neil Solomons
KKR FlowMod Aggregator LLCBiotechnology
Menlo Park, California · founded 2025 · Equity · 12 investors · Douglas Rohlen, Aftab Kherani
Bambusa Therapeutics, Inc.Biotechnology
Boston, Massachusetts · founded 2024 · Equity · 16 investors · Sean Marett, Helmut Jeggle
ADAPTIN BIO, INC.Biotechnology
Charlotte, North Carolina · founded 2022 · Equity, Options, Convertible · 95 investors · Timothy Maness, Anthony Zook
Vaxess Technologies, Inc.Biotechnology
Cambridge, Massachusetts · Debt, Options · 3 investors · Ann DeWitt, Matthew Dirckx
Iantrek, Inc.Biotechnology
White Plains, New York · Debt, Options, Convertible Promissory Notes · 4 investors · Michael Haydin, Robert Weinreb
20/20 GeneSystems, Inc.Biotechnology
Gaithersburg, Maryland · Debt, Options, Convertible · 3 investors · Jonathan Cohen, Prasanth Reddy
MASLOW HEALTH INC.Biotechnology
Chapel Hill, North Carolina · founded 2023 · Simple Agreement for Future Equity · 1 investors · Kenneth King III, Zachary Schrank
Castle Creek Biosciences, Inc.Biotechnology
Exton, Pennsylvania · Options, Convertible · 30 investors · David Brill, Matthew Crabtree
Grace Therapeutics, Inc.Biotechnology
Princeton, New Jersey · Equity, Options, Convertible · 14 investors · Robert J. DelAversano, Amresh Kumar
Synlico Inc.Biotechnology
South San Francisco, California · founded 2021 · Equity, Options, Convertible Note · 1 investors · Jingwei Lu
Newleos Therapeutics, Inc.Biotechnology
Boston, Massachusetts · founded 2024 · Equity · 11 investors · David Donabedian, Robert Hadfield
Oncocyte CorpBiotechnology
Irvine, California · Equity, Options, Convertible · 12 investors · Louis Silverman, Andrew Last
Areteia Therapeutics, Inc.Biotechnology
Chapel Hill, North Carolina · founded 2022 · Equity · 16 investors · Benjamin Gomez, Adam Koppel
Areteia Therapeutics, Inc.Biotechnology
Chapel Hill, North Carolina · founded 2022 · Equity · 16 investors · Benjamin Gomez, Adam Koppel
Kestrel Therapeutics Inc.Biotechnology
Boston, Massachusetts · founded 2020 · Debt, Options, Convertible · 7 investors · Nicholas Saccomano, Barbara Sosnowski
Quarry Thera, LLCBiotechnology
New Haven, Connecticut · founded 2024 · Debt, Options, Convertible Promissory Notes · 1 investors · Dan McHugh, Craig Crews
Flavocure Biotech, Inc.Biotechnology
Baltimore, Maryland · Equity · 3 investors · Ngeh Toyang, Justin Grant
Mercury Bio, Inc.Biotechnology
Santa Fe, New Mexico · founded 2020 · Equity · 1 investors · Bruce McCormick, Mike Rice
Kytopen Corp.Biotechnology
Cambridge, Massachusetts · Equity, Series AA Preferred Stock · 13 investors · Cullen Buie, Julio Vega